Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Tiny sensors could revolutionize jaundice treatment for newborns

NCT ID NCT07057635

Knowledge-focused Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new wireless sensor that continuously measures the light dose babies receive during phototherapy for jaundice. Currently, doctors check light levels only once a day with a handheld device, which can be inaccurate. The sensor aims to provide real-time data to ensure babies get the right amount of treatment. Nine newborns in the NICU will be enrolled to compare the sensor's readings with standard measurements.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
wireless irradiance sensor (bilisensor)
What this could lead to
If successful, this could lead to better, real-time monitoring of phototherapy for newborns with jaundice, potentially improving treatment accuracy.
What could go wrong
This is a very small, early-stage study with only 9 participants, so results may not apply broadly. The device may have data gaps or accuracy issues.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

9 people

The number who actually took part.

Started

Jul 2025

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Any micro premature, preterm or term neonate admitted to NICU undergoing phototherapy due to indirect hyperbilirubinemia will be considered for this pilot study. A convenience sample size of 6 patients will be enrolled.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Participants must be admitted to the Montreal Children's Hospital (MCH) Neonatal Intensive Care Unit (NICU) * Under phototherapy as clinically indicated * Diagnosis of indirect hyperbilirubinemia * Weight of \>1000g at time of enrollment Exclusion Criteria: * Any abnormal skin conditions (example: extreme dryness, desquamation, congenital skin disorders, etc.) * Diagnosis of direct hyperbilirubinemia * Weight of \<1000g at time of enrollment * Any baby or family deemed ineligible (ex. too much stress, too unstable) by the clinical care team

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Jaundice, neonatal are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

hyperbilirubinemia Hyperbilirubinemia, Neonatal Jaundice, Neonatal perinatal disease transient familial neonatal hyperbilirubinemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Jaundice, neonatal Neonatal hyperbilirubinemia Newborn complication Phototherapy complication

Contacts and locations

Locations

  • Montreal Children's Hospital

    Montreal, Quebec, H4A 3H9, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.